These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24297335)

  • 1. Changes in the expression of cyclin G2 in esophageal cancer cell and its significance.
    Chen JQ; Liu CJ; Wen HX; Shi CL; Zhang HS; Li M; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3355-62. PubMed ID: 24297335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in expression of cyclin G2 in kidney cancer cell and its significance.
    Cui DW; Sun GG; Cheng YJ
    Tumour Biol; 2014 Apr; 35(4):3177-83. PubMed ID: 24272084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
    Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
    Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.
    Cui DW; Cheng YJ; Jing SW; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3017-24. PubMed ID: 24293374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.
    Sun GG; Zhang J; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3339-46. PubMed ID: 24307622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma.
    Sun GG; Hu WN; Cui DW; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2631-9. PubMed ID: 24248541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
    Sun GG; Sheng SH; Jing SW; Hu WN
    Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
    Xiao X; Zhou L; Cao P; Gong H; Zhang Y
    Int J Oncol; 2015 Jan; 46(1):161-74. PubMed ID: 25309979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2967-74. PubMed ID: 24218340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
    Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
    Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
    Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
    Sheng SH; Zhao CM; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma.
    Qin WJ; Wang WP; Wang XB; Zhang XT; Du JD
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10332-10342. PubMed ID: 31841213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMP1 regulates caspase-9 and VEGFC expression and suppresses prostate cancer cell proliferation and invasion.
    Sun GG; Wang YD; Cui DW; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3455-62. PubMed ID: 24338711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCNG2 and CDK4 is associated with insulin resistance in adipose tissue.
    Garrido-Sánchez L; Roca-Rodríguez Mdel M; Fernández-Veledo S; Vendrell J; Yubero-Serrano EM; Ocaña-Wilhelmi L; García-Fuentes E; Tinahones FJ
    Surg Obes Relat Dis; 2014; 10(4):691-6. PubMed ID: 24708911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway.
    Qiao P; Li S; Zhang H; Yao L; Wang F
    Oncol Rep; 2018 Oct; 40(4):2067-2078. PubMed ID: 30106441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMP1, a member of a new family of antiproliferative genes in breast carcinoma.
    Sun GG; Wang YD; Lu YF; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3347-54. PubMed ID: 24402572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.